BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1027 related articles for article (PubMed ID: 27400898)

  • 21. Early and mid-term outcomes of 1904 patients undergoing transcatheter balloon-expandable valve implantation in Italy: results from the Italian Transcatheter Balloon-Expandable Valve Implantation Registry (ITER).
    Salizzoni S; D'Onofrio A; Agrifoglio M; Colombo A; Chieffo A; Cioni M; Besola L; Regesta T; Rapetto F; Tarantini G; Napodano M; Gabbieri D; Saia F; Tamburino C; Ribichini F; Cugola D; Aiello M; Sanna F; Iadanza A; Pompei E; Stefàno P; Cappai A; Minati A; Cassese M; Martinelli GL; Agostinelli A; Fiorilli R; Casilli F; Reale M; Bedogni F; Petronio AS; Mozzillo RA; Bonmassari R; Briguori C; Liso A; Sardella G; Bruschi G; Fiorina C; Filippini C; Moretti C; D'Amico M; La Torre M; Conrotto F; Di Bartolomeo R; Gerosa G; Rinaldi M;
    Eur J Cardiothorac Surg; 2016 Dec; 50(6):1139-1148. PubMed ID: 27406375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1-Year Outcomes of the CENTERA-EU Trial Assessing a Novel Self-Expanding Transcatheter Heart Valve.
    Tchétché D; Windecker S; Kasel AM; Schaefer U; Worthley S; Linke A; Abdel-Wahab M; Le Breton H; Søndergaard L; Spence MS; Petronio S; Baumgartner H; Hovorka T; Blanke P; Reichenspurner H
    JACC Cardiovasc Interv; 2019 Apr; 12(7):673-680. PubMed ID: 30947942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A).
    Elmariah S; Palacios IF; McAndrew T; Hueter I; Inglessis I; Baker JN; Kodali S; Leon MB; Svensson L; Pibarot P; Douglas PS; Fearon WF; Kirtane AJ; Maniar HS; Passeri JJ;
    Circ Cardiovasc Interv; 2013 Dec; 6(6):604-14. PubMed ID: 24221391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Mechanically Expanded vs Self-Expanding Transcatheter Aortic Valve Replacement on Mortality and Major Adverse Clinical Events in High-Risk Patients With Aortic Stenosis: The REPRISE III Randomized Clinical Trial.
    Feldman TE; Reardon MJ; Rajagopal V; Makkar RR; Bajwa TK; Kleiman NS; Linke A; Kereiakes DJ; Waksman R; Thourani VH; Stoler RC; Mishkel GJ; Rizik DG; Iyer VS; Gleason TG; Tchétché D; Rovin JD; Buchbinder M; Meredith IT; Götberg M; Bjursten H; Meduri C; Salinger MH; Allocco DJ; Dawkins KD
    JAMA; 2018 Jan; 319(1):27-37. PubMed ID: 29297076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Short-Term Complications on Mortality and Quality of Life After Transcatheter Aortic Valve Replacement.
    Arnold SV; Zhang Y; Baron SJ; McAndrew TC; Alu MC; Kodali SK; Kapadia S; Thourani VH; Miller DC; Mack MJ; Leon MB; Cohen DJ
    JACC Cardiovasc Interv; 2019 Feb; 12(4):362-369. PubMed ID: 30784641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of aortic annulus size on valve hemodynamics and clinical outcomes after transcatheter and surgical aortic valve replacement: insights from the PARTNER Trial.
    Rodés-Cabau J; Pibarot P; Suri RM; Kodali S; Thourani VH; Szeto WY; Svensson LG; Dumont E; Xu K; Hahn RT; Leon MB
    Circ Cardiovasc Interv; 2014 Oct; 7(5):701-11. PubMed ID: 25270901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-Term Outcomes for Patients With Severe Symptomatic Aortic Stenosis Treated With Transcatheter Aortic Valve Implantation.
    Codner P; Orvin K; Assali A; Sharony R; Vaknin-Assa H; Shapira Y; Schwartzenberg S; Bental T; Sagie A; Kornowski R
    Am J Cardiol; 2015 Nov; 116(9):1391-8. PubMed ID: 26342515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes after transfemoral transcatheter aortic valve replacement: a comparison of the randomized PARTNER (Placement of AoRTic TraNscathetER Valves) trial with the NRCA (Nonrandomized Continued Access) registry.
    Fearon WF; Kodali S; Doshi D; Fischbein MP; Yeung AC; Tuzcu EM; Rihal CS; Babaliaros V; Zajarias A; Herrmann HC; Brown DL; Mack M; Teirstein PS; Whisenant BK; Makkar R; Kapadia S; Leon MB;
    JACC Cardiovasc Interv; 2014 Nov; 7(11):1245-51. PubMed ID: 25459036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transaortic transcatheter aortic valve implantation using SAPIEN XT or SAPIEN 3 valves in the ROUTE registry.
    Romano M; Frank D; Cocchieri R; Jagielak D; Bonaros N; Aiello M; Lapeze J; Laine M; Chocron S; Muir D; Eichinger W; Thielmann M; Labrousse L; Arne Rein K; Verhoye JP; Gerosa G; Baumbach H; Deutsch C; Bramlage P; Thoenes M; Bapat V
    Interact Cardiovasc Thorac Surg; 2017 Nov; 25(5):757-764. PubMed ID: 28582580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis.
    Thourani VH; Kodali S; Makkar RR; Herrmann HC; Williams M; Babaliaros V; Smalling R; Lim S; Malaisrie SC; Kapadia S; Szeto WY; Greason KL; Kereiakes D; Ailawadi G; Whisenant BK; Devireddy C; Leipsic J; Hahn RT; Pibarot P; Weissman NJ; Jaber WA; Cohen DJ; Suri R; Tuzcu EM; Svensson LG; Webb JG; Moses JW; Mack MJ; Miller DC; Smith CR; Alu MC; Parvataneni R; D'Agostino RB; Leon MB
    Lancet; 2016 May; 387(10034):2218-25. PubMed ID: 27053442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcatheter Aortic Valve Replacement With the HLT Meridian Valve.
    Rodés-Cabau J; Williams MR; Wijeysundera HC; Kereiakes DJ; Paradis JM; Staniloae C; Saric M; Radhakrishnan S; Wilson RF; Kubo SH
    Circ Cardiovasc Interv; 2019 Aug; 12(8):e008053. PubMed ID: 31362540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transfemoral aortic valve implantation with new-generation devices: the repositionable Lotus vs. the balloon-expandable Edwards Sapien 3 valve.
    Nai Fovino L; Badawy MRA; Fraccaro C; D'Onofrio A; Purita PAM; Frigo AC; Tellaroli P; Mauro A; Tusa M; Napodano M; Gerosa G; Iliceto S; Bedogni F; AbdelRheim AER; Tarantini G
    J Cardiovasc Med (Hagerstown); 2018 Nov; 19(11):655-663. PubMed ID: 30299408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and Impact of Atrial Fibrillation in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: An Analysis From the SOURCE XT Prospective Multicenter Registry.
    Tarantini G; Mojoli M; Windecker S; Wendler O; Lefèvre T; Saia F; Walther T; Rubino P; Bartorelli AL; Napodano M; D'Onofrio A; Gerosa G; Iliceto S; Vahanian A
    JACC Cardiovasc Interv; 2016 May; 9(9):937-46. PubMed ID: 27085579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Preoperative Chronic Kidney Disease in 2,531 High-Risk and Inoperable Patients Undergoing Transcatheter Aortic Valve Replacement in the PARTNER Trial.
    Thourani VH; Forcillo J; Beohar N; Doshi D; Parvataneni R; Ayele GM; Kirtane AJ; Babaliaros V; Kodali S; Devireddy C; Szeto W; Herrmann HC; Makkar R; Ailawadi G; Lim S; Maniar HS; Zajarias A; Suri R; Tuzcu EM; Kapadia S; Svensson L; Condado J; Jensen HA; Mack MJ; Leon MB
    Ann Thorac Surg; 2016 Oct; 102(4):1172-80. PubMed ID: 27592092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Effect of Post-Dilatation on Outcomes in the PARTNER 2 SAPIEN 3 Registry.
    Hahn RT; Pibarot P; Leipsic J; Blanke P; Douglas PS; Weissman NJ; Kapadia S; Thourani VH; Herrmann HC; Nazif T; McAndrew T; Webb JG; Leon MB; Kodali S
    JACC Cardiovasc Interv; 2018 Sep; 11(17):1710-1718. PubMed ID: 30121276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mid-Term Outcomes of Transcatheter Aortic Valve Replacement in Extremely Large Annuli With Edwards SAPIEN 3 Valve.
    Sengupta A; Zaid S; Kamioka N; Terre J; Miyasaka M; Hirji SA; Hensey M; Geloo N; Petrossian G; Robinson N; Sarin E; Ryan L; Yoon SH; Tan CW; Khalique OK; Kodali SK; Kaneko T; Shah PB; Wong SC; Salemi A; Sharma K; Kozina JA; Szerlip MA; Don CW; Gafoor S; Zhang M; Newhart Z; Kapadia SR; Mick SL; Krishnaswamy A; Kini A; Ahmad H; Lansman SL; Mack MJ; Webb JG; Babaliaros V; Thourani VH; Makkar RR; Leon MB; George I; Tang GHL
    JACC Cardiovasc Interv; 2020 Jan; 13(2):210-216. PubMed ID: 31883715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transaortic transcatheter aortic valve implantation: Results of the Polish arm of the ROUTE registry.
    Jagielak D; Bramlage P; Pawlaczyk R; Brzeziński M; Fijałkowski M; Łaskawski G; Ciećwierz D; Rogowski J; Kozaryn R
    Cardiol J; 2015; 22(6):651-6. PubMed ID: 26202653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early clinical outcome of aortic transcatheter valve-in-valve implantation in the Nordic countries.
    Ihlberg L; Nissen H; Nielsen NE; Rück A; Busund R; Klaarborg KE; Soendergaard L; Harnek J; Miettinen H; Eskola M; Wahba A; Laine M
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1047-54; discussion 1054. PubMed ID: 23998786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcatheter Aortic Valve Replacement With a Repositionable Self-Expanding Prosthesis: The PORTICO-I Trial 1-Year Outcomes.
    Søndergaard L; Rodés-Cabau J; Hans-Peter Linke A; Fichtlscherer S; Schäfer U; Kuck KH; Kempfert J; Arzamendi D; Bedogni F; Asch FM; Worthley S; Maisano F
    J Am Coll Cardiol; 2018 Dec; 72(23 Pt A):2859-2867. PubMed ID: 30261238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 2-Year Outcomes After Iliofemoral Self-Expanding Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis Deemed Extreme Risk for Surgery.
    Yakubov SJ; Adams DH; Watson DR; Reardon MJ; Kleiman NS; Heimansohn D; Hermiller J; Hughes GC; Harrison JK; Coselli J; Diez J; Schreiber T; Gleason TG; Conte J; Deeb GM; Huang J; Oh J; Byrne T; Caskey M; Popma JJ;
    J Am Coll Cardiol; 2015 Sep; 66(12):1327-34. PubMed ID: 26383718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.